Ezzat AA - Search Results

1

HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer.

Tulbah AM, Ibrahim EM, Ezzat AA, Ajarim DS, Rahal MM, El Weshi AN, Sorbris R. Tulbah AM, et al. Among authors: ezzat aa. Med Oncol. 2002;19(1):15-23. doi: 10.1385/MO:19:1:15. Med Oncol. 2002. PMID: 12025887

2

Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy.

Baslaim MM, Al Malik OA, Al-Sobhi SS, Ibrahim E, Ezzat A, Ajarim D, Tulbah A, Chaudhary MA, Sorbris RA. Baslaim MM, et al. Am J Surg. 2002 Oct;184(4):299-301. doi: 10.1016/s0002-9610(02)00959-5. Am J Surg. 2002. PMID: 12383887

3

Adjuvant chemotherapy in 780 patients with early breast cancer: 10-year data from Saudi Arabia.

Ibrahim EM, Ezzat AA, Rahal MM, Raja MM, Ajarim DS. Ibrahim EM, et al. Among authors: ezzat aa. Med Oncol. 2005;22(4):343-52. doi: 10.1385/MO:22:4:343. Med Oncol. 2005. PMID: 16260851

4

Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors.

Al Sayed AD, El Weshi AN, Tulbah AM, Rahal MM, Ezzat AA. Al Sayed AD, et al. Among authors: ezzat aa. Acta Oncol. 2006;45(2):188-95. doi: 10.1080/02841860500513235. Acta Oncol. 2006. PMID: 16546865

5

The present and the future of breast cancer burden in the Kingdom of Saudi Arabia.

Ibrahim EM, Zeeneldin AA, Sadiq BB, Ezzat AA. Ibrahim EM, et al. Among authors: ezzat aa. Med Oncol. 2008;25(4):387-93. doi: 10.1007/s12032-008-9051-5. Epub 2008 Mar 4. Med Oncol. 2008. PMID: 18317955

6

Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer.

Al-Tweigeri TA, Ajarim DS, Alsayed AA, Rahal MM, Alshabanah MO, Tulbah AM, Al-Malik OA, Fatani DM, El-Husseiny GA, Elkum NB, Ezzat AA. Al-Tweigeri TA, et al. Among authors: ezzat aa. Med Oncol. 2010 Sep;27(3):571-7. doi: 10.1007/s12032-009-9251-7. Epub 2009 Jun 13. Med Oncol. 2010. PMID: 19526202 Clinical Trial.

7

Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population.

Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S, Rostom A, Stuart RK. Ezzat AA, et al. Med Oncol. 1999 Jul;16(2):95-103. doi: 10.1007/BF02785842. Med Oncol. 1999. PMID: 10456657

8

Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma.

Ibrahim EM, Ezzat AA, Raja MA, Rahal MM, Ajarim DS, Mann B, Baloush A, Stuart RK, Bazarbashi SN. Ibrahim EM, et al. Among authors: ezzat aa. Ann Oncol. 1999 Dec;10(12):1441-9. doi: 10.1023/a:1008325823967. Ann Oncol. 1999. PMID: 10643534 Free article.

9

Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial.

Ezzat AA, Ibrahim EM, Stuart RK, Ajarim D, Bazarbashi S, El-Foudeh MO, Rahal M, Al-Sayed A, Berry J. Ezzat AA, et al. Med Oncol. 2000 Feb;17(1):39-46. doi: 10.1007/BF02826215. Med Oncol. 2000. PMID: 10713659 Clinical Trial.

10

High complete pathological response in locally advanced breast cancer using paclitaxel and cisplatin.

Ezzat AA, Ibrahim EM, Ajarim DS, Rahal MM, Raja MA, Stuart RK, Tulbah AM, Kandil A, Al-Malik OA, Bazarbashi SM. Ezzat AA, et al. Breast Cancer Res Treat. 2000 Aug;62(3):237-44. doi: 10.1023/a:1006434406989. Breast Cancer Res Treat. 2000. PMID: 11072788 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters